Work

Abstract A04: Targeted protein degradation as a strategy to overcome non-covalent BTK inhibitor resistance in lymphoma

Year: 2022

Type: conference-abstract

Source: Blood Cancer Discovery

DOI: 10.1158/2643-3249.lymphoma22-a04

Authors: Skye Montoya, Eric Wang, Jessie Bourcier, Sana Chaudhry, Tulasigeri Totiger, Alejandro Pardo, Gabriel Pardo, Maurizio Affer, Jacob Jahn, Anthony Mato, Omar Abdel-Wahab, Justin Taylor

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4294771631

Cites:

Cited by:

Related to: 10